Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Srikanth Vallurupalli

Concepts (295)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Coronary Artery Disease
12
2024
323
4.130
Why?
Atrial Fibrillation
5
2022
196
2.310
Why?
Percutaneous Coronary Intervention
9
2022
328
2.270
Why?
Ventricular Function, Right
6
2025
40
2.200
Why?
Ventricular Dysfunction, Right
3
2023
31
2.190
Why?
Echocardiography
13
2025
409
2.070
Why?
Aortic Valve Stenosis
5
2021
79
2.030
Why?
Stents
8
2022
368
1.920
Why?
Angioplasty, Balloon, Coronary
4
2018
168
1.860
Why?
Myocardial Infarction
5
2024
449
1.740
Why?
Echocardiography, Doppler
3
2025
56
1.480
Why?
Endocarditis
2
2022
31
1.280
Why?
Aortic Valve
3
2020
130
1.240
Why?
Thrombocytopenia
2
2022
93
1.240
Why?
Treatment Outcome
26
2022
5508
1.200
Why?
Electrocardiography
6
2024
273
1.170
Why?
Humans
70
2025
52441
1.170
Why?
Heart Ventricles
6
2025
259
1.120
Why?
Fractional Flow Reserve, Myocardial
4
2022
127
1.080
Why?
Heart Failure
6
2022
527
1.020
Why?
Ischemic Attack, Transient
2
2018
60
1.020
Why?
Veterans
2
2022
573
0.930
Why?
Pulmonary Artery
2
2025
142
0.900
Why?
Stroke
3
2021
527
0.890
Why?
Exercise Test
3
2024
134
0.820
Why?
Coronary Stenosis
2
2021
98
0.810
Why?
Coronary Angiography
9
2022
367
0.790
Why?
Risk Factors
16
2022
3971
0.770
Why?
Thrombosis
3
2024
250
0.770
Why?
Electric Countershock
1
2022
30
0.730
Why?
Endocarditis, Bacterial
1
2022
43
0.730
Why?
Atrial Appendage
1
2021
14
0.720
Why?
Anemia
1
2022
75
0.710
Why?
Kidney Diseases
3
2021
230
0.710
Why?
Retrospective Studies
16
2023
6694
0.700
Why?
Catheter Ablation
2
2021
125
0.690
Why?
Anticholesteremic Agents
1
2021
31
0.690
Why?
Hypercholesterolemia
1
2021
39
0.680
Why?
Cryosurgery
1
2021
36
0.670
Why?
Systole
4
2023
71
0.660
Why?
Male
33
2025
26874
0.640
Why?
Magnetic Resonance Imaging, Cine
3
2016
64
0.640
Why?
Operative Time
2
2017
76
0.640
Why?
Dyspnea
3
2018
78
0.630
Why?
Heart
2
2021
352
0.630
Why?
Predictive Value of Tests
10
2022
938
0.630
Why?
Digitalis
1
2019
4
0.620
Why?
Anticoagulants
3
2022
276
0.610
Why?
Aged
21
2025
10242
0.610
Why?
Middle Aged
23
2025
13133
0.580
Why?
Cardiac Catheters
1
2018
12
0.570
Why?
Auscultation
1
2018
9
0.560
Why?
Female
29
2025
28277
0.560
Why?
Heart Murmurs
1
2018
14
0.560
Why?
Asymptomatic Diseases
1
2018
38
0.560
Why?
Time Factors
9
2022
2987
0.540
Why?
Coronary Disease
2
2015
145
0.530
Why?
Heart Diseases
2
2017
217
0.530
Why?
Artifacts
1
2017
53
0.530
Why?
Drug Prescriptions
1
2018
112
0.530
Why?
Peripheral Arterial Disease
1
2018
78
0.520
Why?
Hydroxymethylglutaryl-CoA Reductase Inhibitors
1
2018
148
0.510
Why?
Mediastinal Neoplasms
1
2017
19
0.510
Why?
Hospital Mortality
2
2018
451
0.510
Why?
Coronary Occlusion
1
2017
80
0.500
Why?
Surgical Procedures, Operative
1
2017
66
0.490
Why?
Absorbable Implants
1
2016
13
0.490
Why?
Tomography, Optical Coherence
1
2017
110
0.490
Why?
Pneumonia
1
2017
122
0.480
Why?
Respiratory Insufficiency
1
2017
114
0.470
Why?
Acute Coronary Syndrome
1
2017
106
0.470
Why?
Propafenone
1
2015
2
0.470
Why?
Tachycardia, Ectopic Atrial
1
2015
3
0.470
Why?
Flecainide
1
2015
4
0.470
Why?
Heart Conduction System
1
2015
24
0.460
Why?
Hypoparathyroidism
1
2015
5
0.460
Why?
Hypocalcemia
1
2015
13
0.460
Why?
Prognosis
6
2024
2100
0.460
Why?
Rhabdomyolysis
1
2015
11
0.460
Why?
Heart Rate
2
2021
311
0.450
Why?
Clinical Competence
1
2018
405
0.450
Why?
Thyroidectomy
1
2015
61
0.440
Why?
Cardiac Surgical Procedures
2
2017
329
0.430
Why?
Physician-Patient Relations
1
2015
142
0.420
Why?
Heart Neoplasms
1
2014
30
0.420
Why?
Fibroma
1
2014
40
0.420
Why?
Ventricular Function, Left
4
2019
174
0.410
Why?
Recurrence
4
2021
680
0.400
Why?
Theophylline
1
2013
20
0.400
Why?
Syncope
1
2013
31
0.390
Why?
Diabetes Mellitus, Type 2
4
2022
570
0.380
Why?
Physicians
1
2015
237
0.370
Why?
Heart Valve Prosthesis
2
2022
89
0.350
Why?
Heart Valve Prosthesis Implantation
2
2022
103
0.340
Why?
Stroke Volume
3
2025
148
0.340
Why?
Amyloidosis
3
2016
85
0.340
Why?
Arkansas
6
2019
2013
0.320
Why?
Octreotide
1
2010
9
0.320
Why?
Sulfonylurea Compounds
1
2010
7
0.320
Why?
Head and Neck Neoplasms
1
2013
289
0.320
Why?
Benzocaine
1
2009
3
0.320
Why?
Ventricular Remodeling
3
2021
65
0.310
Why?
Methemoglobinemia
1
2009
5
0.310
Why?
Hypoglycemia
1
2010
62
0.300
Why?
Diagnosis, Differential
3
2018
1028
0.300
Why?
Echocardiography, Transesophageal
1
2009
60
0.300
Why?
Anesthetics, Local
1
2009
77
0.300
Why?
Prospective Studies
3
2023
2433
0.280
Why?
Prosthesis Design
3
2022
262
0.280
Why?
Vasodilator Agents
2
2022
90
0.280
Why?
Reproducibility of Results
3
2025
1223
0.280
Why?
Myocardial Contraction
2
2019
109
0.270
Why?
Incidence
5
2019
1096
0.270
Why?
Coronary Vessels
2
2020
169
0.260
Why?
Chronic Disease
3
2018
579
0.250
Why?
Pressure
2
2017
100
0.250
Why?
Defibrillators, Implantable
2
2019
63
0.240
Why?
Ventricular Outflow Obstruction
1
2025
27
0.230
Why?
Randomized Controlled Trials as Topic
5
2022
625
0.230
Why?
Follow-Up Studies
5
2019
2294
0.220
Why?
Cardiomyopathies
2
2016
117
0.220
Why?
Foramen Ovale, Patent
2
2015
31
0.220
Why?
Cardiac Catheterization
3
2022
228
0.220
Why?
Myxoma
1
2024
17
0.210
Why?
Hepatitis C, Chronic
2
2015
86
0.210
Why?
Adult
9
2025
14205
0.200
Why?
Hospitalization
4
2022
731
0.200
Why?
Risk Assessment
4
2022
1349
0.190
Why?
Mitral Valve Insufficiency
1
2022
56
0.190
Why?
Bioprosthesis
1
2022
40
0.180
Why?
Electrodes
1
2022
35
0.180
Why?
Proportional Hazards Models
3
2020
446
0.180
Why?
Warfarin
1
2022
81
0.180
Why?
Multiple Myeloma
4
2017
3013
0.180
Why?
Pilot Projects
2
2022
725
0.180
Why?
Glycosides
1
2020
15
0.170
Why?
Sodium-Glucose Transporter 1
1
2020
6
0.170
Why?
Severity of Illness Index
2
2018
1045
0.170
Why?
Microscopy, Fluorescence, Multiphoton
1
2020
7
0.170
Why?
Vasodilation
1
2021
99
0.170
Why?
Tachycardia, Supraventricular
1
2021
36
0.170
Why?
United States
3
2022
5215
0.170
Why?
Calcinosis
1
2020
48
0.170
Why?
Cardiovascular System
1
2020
55
0.170
Why?
United States Department of Veterans Affairs
1
2022
291
0.160
Why?
Blood Pressure
1
2022
525
0.160
Why?
Digoxin
1
2019
21
0.160
Why?
Heart Failure, Systolic
1
2019
7
0.150
Why?
Inpatients
2
2018
203
0.150
Why?
Electric Stimulation Therapy
1
2019
22
0.150
Why?
Cardiotonic Agents
1
2019
70
0.150
Why?
Metoprolol
1
2019
13
0.150
Why?
Kaplan-Meier Estimate
2
2017
485
0.150
Why?
Platelet Transfusion
1
2018
33
0.150
Why?
Cerebrovascular Disorders
1
2018
46
0.140
Why?
Hepatitis C Antibodies
2
2015
19
0.140
Why?
Delivery of Health Care
1
2021
317
0.140
Why?
Cardiovascular Diseases
3
2020
493
0.140
Why?
Databases, Factual
2
2018
721
0.130
Why?
Renal Insufficiency, Chronic
1
2020
198
0.130
Why?
Cardiac Imaging Techniques
1
2017
8
0.130
Why?
Fever
1
2018
112
0.130
Why?
Logistic Models
2
2017
930
0.130
Why?
Hepacivirus
2
2015
103
0.130
Why?
Cell Transdifferentiation
1
2017
8
0.130
Why?
Xanthine Oxidase
1
2017
13
0.130
Why?
Foam Cells
1
2017
17
0.130
Why?
Hemorrhage
1
2018
225
0.130
Why?
Survival Rate
2
2019
944
0.130
Why?
Respiratory Sounds
1
2017
50
0.130
Why?
Cohort Studies
2
2018
1576
0.130
Why?
Myocytes, Smooth Muscle
1
2017
95
0.130
Why?
Radiographic Image Enhancement
1
2016
30
0.120
Why?
Gadolinium DTPA
1
2016
26
0.120
Why?
Chi-Square Distribution
1
2017
292
0.120
Why?
Inflammasomes
1
2017
64
0.120
Why?
Propensity Score
1
2017
160
0.120
Why?
Muscle, Smooth, Vascular
1
2017
135
0.120
Why?
Kidney
1
2020
716
0.120
Why?
Magnetic Resonance Imaging
3
2024
1507
0.120
Why?
Quality Improvement
1
2018
226
0.120
Why?
Voltage-Gated Sodium Channel Blockers
1
2015
5
0.120
Why?
Ventricular Function
1
2015
17
0.120
Why?
Intermittent Claudication
1
2015
16
0.120
Why?
Fundoplication
1
2015
20
0.120
Why?
Healthcare Disparities
1
2018
291
0.120
Why?
Postpericardiotomy Syndrome
1
2015
4
0.110
Why?
Supine Position
1
2015
26
0.110
Why?
Immobilization
1
2015
15
0.110
Why?
Goiter
1
2015
5
0.110
Why?
Pericardiectomy
1
2015
6
0.110
Why?
Colchicine
1
2015
24
0.110
Why?
Length of Stay
1
2018
673
0.110
Why?
Pericarditis
1
2015
20
0.110
Why?
Aged, 80 and over
3
2018
3449
0.110
Why?
Mucolipidoses
1
2014
4
0.110
Why?
Scavenger Receptors, Class E
1
2017
200
0.110
Why?
Secondary Prevention
1
2015
85
0.110
Why?
Carcinoma, Renal Cell
1
2015
112
0.110
Why?
Thoracotomy
1
2014
33
0.110
Why?
Sulfonamides
1
2015
137
0.110
Why?
Obesity, Morbid
1
2015
86
0.110
Why?
Septal Occluder Device
1
2014
36
0.100
Why?
Pyrimidines
1
2015
199
0.100
Why?
Kidney Neoplasms
1
2015
181
0.100
Why?
Bone Marrow Transplantation
1
2014
110
0.100
Why?
Laparoscopy
1
2015
180
0.100
Why?
Mitral Valve
2
2022
57
0.090
Why?
Prosthesis Failure
2
2022
112
0.090
Why?
Administration, Oral
1
2013
455
0.090
Why?
Tomography, X-Ray Computed
1
2017
1140
0.090
Why?
Postoperative Complications
2
2015
1065
0.090
Why?
Injections, Subcutaneous
1
2010
54
0.080
Why?
Pericardium
1
2010
32
0.080
Why?
Gastrointestinal Agents
1
2010
41
0.080
Why?
Drug Monitoring
1
2010
81
0.080
Why?
Antineoplastic Combined Chemotherapy Protocols
1
2015
1020
0.080
Why?
Quality of Life
1
2015
893
0.080
Why?
Cause of Death
2
2020
157
0.070
Why?
Lipid Metabolism
1
2010
189
0.070
Why?
Renal Dialysis
1
2010
189
0.070
Why?
Kidney Failure, Chronic
1
2010
205
0.070
Why?
Dose-Response Relationship, Drug
1
2010
1365
0.060
Why?
Exercise
1
2010
559
0.060
Why?
Oxidative Stress
1
2010
805
0.060
Why?
Blood Flow Velocity
1
2025
97
0.060
Why?
Disease Progression
2
2020
870
0.060
Why?
RNA, Viral
2
2015
123
0.050
Why?
Gadolinium
1
2024
44
0.050
Why?
Heart Atria
1
2024
62
0.050
Why?
Sensitivity and Specificity
1
2025
871
0.050
Why?
Contrast Media
1
2024
173
0.050
Why?
Vitamin K
1
2022
17
0.050
Why?
American Heart Association
1
2022
44
0.050
Why?
Telemetry
1
2021
27
0.040
Why?
Tachycardia
1
2021
28
0.040
Why?
Acute Disease
1
2022
384
0.040
Why?
Glucosides
1
2020
21
0.040
Why?
Diabetic Ketoacidosis
1
2020
17
0.040
Why?
Platelet Aggregation Inhibitors
1
2022
211
0.040
Why?
Glomerular Filtration Rate
1
2020
126
0.040
Why?
Early Diagnosis
1
2020
84
0.040
Why?
Benzhydryl Compounds
1
2020
70
0.040
Why?
Exercise Tolerance
1
2019
42
0.040
Why?
Death, Sudden, Cardiac
1
2019
55
0.040
Why?
Anti-Arrhythmia Agents
1
2019
79
0.040
Why?
Recovery of Function
1
2019
201
0.040
Why?
Oxygen Consumption
1
2019
193
0.040
Why?
Adrenergic beta-Antagonists
1
2019
107
0.040
Why?
Feasibility Studies
1
2020
404
0.040
Why?
Uric Acid
1
2017
25
0.030
Why?
Scavenger Receptors, Class A
1
2017
39
0.030
Why?
Referral and Consultation
1
2018
288
0.030
Why?
Registries
1
2020
638
0.030
Why?
RNA Interference
1
2017
183
0.030
Why?
Transfection
1
2017
365
0.030
Why?
Biopsy, Needle
1
2016
181
0.030
Why?
Disease Models, Animal
1
2020
1483
0.030
Why?
ROC Curve
1
2016
249
0.030
Why?
Hernia, Hiatal
1
2015
9
0.030
Why?
Patient Acceptance of Health Care
1
2018
351
0.030
Why?
Mice, Inbred C57BL
1
2020
1888
0.030
Why?
Gastroesophageal Reflux
1
2015
50
0.030
Why?
Tubulin Modulators
1
2015
28
0.030
Why?
Indazoles
1
2015
47
0.030
Why?
Reactive Oxygen Species
1
2017
415
0.030
Why?
Seroepidemiologic Studies
1
2014
43
0.030
Why?
Multivariate Analysis
1
2016
601
0.030
Why?
Biopsy
1
2016
594
0.030
Why?
Survival Analysis
1
2016
656
0.030
Why?
Pneumonectomy
1
2014
29
0.030
Why?
Angiogenesis Inhibitors
1
2015
183
0.030
Why?
Prosthesis Implantation
1
2014
48
0.030
Why?
Posture
1
2014
66
0.030
Why?
Anti-Inflammatory Agents
1
2015
166
0.030
Why?
Myocardium
1
2016
471
0.030
Why?
Immunohistochemistry
1
2016
977
0.030
Why?
Polymerase Chain Reaction
1
2014
458
0.030
Why?
Age Distribution
1
2013
176
0.030
Why?
Syndrome
1
2014
247
0.030
Why?
Cell Line, Tumor
1
2017
1429
0.020
Why?
Ventricular Dysfunction, Left
1
2014
107
0.020
Why?
Transplantation, Autologous
1
2014
479
0.020
Why?
Comorbidity
1
2013
637
0.020
Why?
Oxygen
1
2014
332
0.020
Why?
alpha-2-HS-Glycoprotein
1
2010
2
0.020
Why?
Thiobarbituric Acid Reactive Substances
1
2010
10
0.020
Why?
Signal Transduction
1
2017
1724
0.020
Why?
Blood Proteins
1
2010
84
0.020
Why?
C-Reactive Protein
1
2010
151
0.020
Why?
Interleukin-6
1
2010
271
0.020
Why?
Lung Neoplasms
1
2014
643
0.020
Why?
Animals
1
2020
13485
0.010
Why?
Young Adult
1
2013
4346
0.010
Why?
Adolescent
1
2013
6713
0.010
Why?
Vallurupalli's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description